Medical News

RSS

Gut bacteria can take control over the host animal's sensory behavior

Gut bacteria are tiny but may play an outsized role not only in the host animal's digestive health, but in their overall well-being.

17 Jun 2020

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Previous studies have shown that low-dose, whole lung radiation in the form of X-rays can effectively treat severe pneumonia, with minimal side effects.

17 Jun 2020

UVA doctors and students launch 12-part COVID-19 podcast series

UVA School of Medicine physicians and students have launched a COVID-19 podcast series that includes advice to protect your health along with a behind-the-scenes look at UVA Health's patient care and research.

17 Jun 2020

Study: Nearly 10% of patients continue to use opioids more than 90 days after heart surgery

Nearly 10 percent of patients who are prescribed opioid medications following heart surgery will continue to use opioids more than 90 days after the procedure, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.

17 Jun 2020

BU receives grant to address the unique needs of female veterans

Boston University School of Medicine's Women Veterans Network has received one of 13 grants (out of 190 initial proposals) from the Bob Woodruff Foundation.

17 Jun 2020

Citing COVID, Sutter pushes to revisit landmark antitrust settlement

Six months after agreeing to a $575 million settlement in a closely watched antitrust case filed by California Attorney General Xavier Becerra, Sutter Health has yet to pay a single dollar, and no operational changes have gone into effect.

17 Jun 2020

Discovery could significantly improve diagnosis of motor neuron disease

Scientists at the University of Sussex have identified a potential pattern within blood which signals the presence of motor neuron disease; a discovery which could significantly improve diagnosis.

17 Jun 2020

California taps libraries and tax offices to recruit 20,000 new disease detectives

After more than two months at home, librarian Lisa Fagundes misses managing her sci-fi book collection so much, she feels she’s in withdrawal, longing to see new books, touch them, smell them. “It’s like a disease,” she said, laughing.

17 Jun 2020

Social norms may influence the consumption of risky food

Who can make you eat pink hamburgers or uncooked chicken? Your future parents-in-law, research shows. Even though you know and feel that eating certain food is risky, the social norms governing the eating situation may make you eat it anyway.

17 Jun 2020

Time-driven activity-based costing can be an effective strategy to support value-based healthcare

Value in Health, the official journal of ISPOR - the professional society for health economics and outcomes research, announced today the publication of results of a study suggesting that time-driven activity-based costing can be an effective technique to support value-based healthcare initiatives.

17 Jun 2020

New nanoparticle drug combination can help treat atherosclerosis

Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

17 Jun 2020

Nanosponges could attack and neutralize SARS-COV-2 virus

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

17 Jun 2020

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases.

17 Jun 2020

Study highlights the lasting positive effect of a reward on memory

How does our memory work and how can we optimize its mechanisms on a daily basis? This question is at the heart of many neuroscience research projects.

17 Jun 2020

User-friendly support system for laboratory scale reactions

The ReactoMate DATUM from Asynt is a high quality, dual-rod stainless steel and aluminium support system built to ensure the stability and safety of your lab reactor. Sturdy, yet compact, the ReactoMate DATUM support system can accommodate a wide range of reaction vessels from 100 mL up to 5000 mL.

From Asynt 17 Jun 2020

Pandemic upends the lives of people with disabilities — and of their caregivers

When the COVID-19 pandemic hit, Stacy Ellingen, 34, of Oshkosh, Wisconsin, lost two of the three caregivers she depends on to dress, shower, eat and use the bathroom. The caregivers — both University of Wisconsin-Oshkosh students — returned to their parents’ homes when the university canceled in-person classes.

17 Jun 2020

Cobra and AstraZeneca sign supply agreement for manufacture of COVID-19 vaccine candidate

Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously known as ChAdOx1 n-CoV-19.

From AstraZeneca 17 Jun 2020

C-OPN accelerates Parkinson’s disease research and treatment

Parkinson Canada invites people living with Parkinson’s disease to join the Canadian Open Parkinson Network to be part of the solution to improve lives for those living with Parkinson’s and ultimately to help discover a cure.

17 Jun 2020

Abbott's FreeStyle Libre system significantly reduces HbA1c levels in patients with type 2 diabetes

Abbott announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading sensor-based glucose monitoring technology, is associated with significant reduction in hemoglobin A1c (HbA1c) levels for people living with type 2 diabetes on either long-acting insulin or non-insulin therapy.

17 Jun 2020

Celltrion announces plans to launch COVID-19 point-of-care antigen testing kit

Celltrion Group today announced plans to expand its diagnostic portfolio for SARS-CoV-2, the virus causing COVID-19, in its efforts to improve access to COVID-19 testing and help prevent the further spread of coronavirus infection worldwide.

17 Jun 2020